Highlights include the company’s strong foundation for growth, focus on innovation and attractive long-term outlookSAN DIEGO, Sept. 29, 2023 Maravai LifeSciences Holdings, Inc. , a global.
Aclaris Therapeutics (NASDAQ:ACRS – Get Free Report) and Maravai LifeSciences (NASDAQ:MRVI – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, risk, profitability and dividends. Profitability This table compares Aclaris Therapeutics and Maravai […]
Operator: Greetings, and welcome to the Fourth Quarter and Year-end 2022 Maravai LifeSciences Earnings Conference Call. Please note that this conference is being recorded.